ACHC
Acadia Healthcare Company, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+43/100
Last price
29.04
▲ 0.17 (0.59%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
28.80
Prev close
28.87
Day high
29.26
Day low
28.43
Volume
1.42M
Market cap
$2.70B
P/E (TTM)
—
52W range
11.43 – 35.83
Day trading desk
Gap from prior close
-0.24%
Prior close 28.87
VWAP
28.97
+0.25% from price
Relative volume
1.16×
Normal
Session range
2.90%
28.43 – 29.25
Position in range
74%
Near session high
ATR (14D)
1.14
3.93% of price
Prior day high
28.92
PDH
Prior day low
27.83
PDL
Bid / ask spread
—
Quote not published
Session volume
2.37M
Avg 2.06M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+3.57%
+1.6%
1M
+3.23%
+2.1%
3M
-5.53%
-10.0%
6M
+14.38%
-3.8%
YTD
+104.65%
+90.4%
1Y
+7.00%
-9.4%
3Y
-58.70%
-140.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ACHC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.43M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 6, 26 | GRIECO WILLIAM F Director |
STOCK | 6.33K | $0 | Direct |
| May 6, 26 | WAUD REEVE B Director |
STOCK | 15.91K | $0 | Direct |
| May 6, 26 | CANCELMI DANIEL J Director |
STOCK | 6.33K | $0 | Direct |
| May 6, 26 | GREGG VICKY B Director |
STOCK | 6.33K | $0 | Direct |
| May 6, 26 | BERNHARD JASON R. Director |
STOCK | 11.46K | $0 | Direct |
| May 6, 26 | HARRIS PATRICE A. Director |
STOCK | 6.33K | $0 | Direct |
| May 6, 26 | FUCCI MICHAEL J. Director |
STOCK | 6.33K | $0 | Direct |
| May 6, 26 | KELLY RALPH DAVID Director |
STOCK | 6.33K | $0 | Direct |
| May 6, 26 | BISSELL E PEROT Director |
STOCK | 11.83K | $0 | Direct |
| Apr 28, 26 | FARLEY BRIAN P Officer |
STOCK | 37.51K | $0 | Direct |
| Apr 10, 26 | FARLEY BRIAN P General Counsel |
STOCK | 37.51K | $0 | Direct |
| Apr 10, 26 | YOUNG TODD S Chief Financial Officer |
STOCK | 58.80K | $0 | Direct |
| Mar 12, 26 | CANCELMI DANIEL J Director |
STOCK | 6.63K | $0 | Direct |
| Oct 27, 25 | YOUNG TODD S Chief Financial Officer |
STOCK | 48.45K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BERNHARD JASON R. |
Director | 45.36K | Stock Award(Grant) |
BISSELL E PEROT |
Director | 57.49K | Stock Award(Grant) |
DIXON HEATHER BRIANNE |
Chief Financial Officer | 122.50K | Stock Award(Grant) |
FARLEY BRIAN P |
Officer | 144.19K | Stock Award(Grant) |
GRIECO WILLIAM F |
Director | 96.21K | Stock Award(Grant) |
HUNTER CHRISTOPHER H |
Chief Executive Officer | 265.88K | Stock Award(Grant) |
KHAN NASSER |
Chief Operating Officer | 56.00K | Stock Award(Grant) |
MIQUELON WADE D |
Director | 55.52K | Stock Award(Grant) |
WAUD REEVE B |
Director | 728.87K | Stock Award(Grant) |
YOUNG TODD S |
Chief Financial Officer | 107.24K | Stock Award(Grant) |
Fundamentals
Market cap$2.70B
Enterprise value$5.33B
Revenue (TTM)$3.37B
Gross profit$1.38B
EBITDA$534.85M
Net income$-1.13B
EPS (TTM)$-12.49
Free cash flow$-104.96M
Total cash$171.29M
Total debt$2.59B
Book value / share$21.78
Shares outstanding93.10M
Float91.53M
Short % of float35.48%
Dividend yield0.00%
Beta (5Y)0.63
Valuation & profitability ratios
Trailing P/E—
Forward P/E15.72
PEG ratio1.37
Price / sales—
Price / book1.33
EV / revenue1.58
EV / EBITDA9.97
Gross margin41.06%
Operating margin10.14%
Profit margin-33.44%
Return on equity-41.45%
Return on assets3.57%
Debt / equity118.06
Current ratio1.57
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.31B | $3.15B | $2.93B | $2.61B | +5.0% |
| Operating revenue | $3.31B | $3.15B | $2.93B | $2.61B | +5.0% |
| Cost of revenue | $118.05M | $112.71M | $105.99M | $100.20M | +4.7% |
| Gross profit | $3.19B | $3.04B | $2.82B | $2.51B | +5.0% |
| Selling, general & admin | $2.06B | $1.93B | $1.79B | $1.60B | +7.0% |
| Total operating expense | $2.81B | $2.52B | $2.31B | $2.04B | +11.4% |
| Operating income | $387.96M | $522.28M | $513.01M | $467.69M | -25.7% |
| Net interest income | -$138.86M | -$116.37M | -$82.13M | -$69.76M | -19.3% |
| Pre-tax income | -$1.07B | $341.88M | -$25.36M | $374.14M | -411.8% |
| Tax provision | $25.98M | $77.39M | -$9.70M | $94.11M | -66.4% |
| Net income | -$1.10B | $255.61M | -$21.67M | $273.14M | -531.4% |
| Net income to common | -$1.10B | $255.61M | -$21.67M | $273.14M | -531.4% |
| Basic EPS | -12.16 | 2.79 | -0.24 | 3.05 | -535.8% |
| Diluted EPS | -12.16 | 2.78 | -0.24 | 2.98 | -537.4% |
| EBIT | -$927.08M | $458.25M | $56.77M | $443.90M | -302.3% |
| EBITDA | -$737.83M | $607.84M | $189.11M | $561.67M | -221.4% |
| Basic shares | 90.70M | 91.62M | 90.95M | 89.68M | -1.0% |
| Diluted shares | 90.70M | 92.06M | 90.95M | 91.56M | -1.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $133.24M | $76.31M | $100.07M | $97.65M | +74.6% |
| Cash & short-term investments | $133.24M | $76.31M | $100.07M | $97.65M | +74.6% |
| Accounts receivable | $440.60M | $365.34M | $361.45M | $322.44M | +20.6% |
| Inventory | $5.69M | $5.65M | $5.30M | $5.09M | +0.6% |
| Total current assets | $814.14M | $577.49M | $596.00M | $506.13M | +41.0% |
| Property, plant & equipment | $3.25B | $2.97B | $2.38B | $2.09B | +9.2% |
| Goodwill & intangibles | $1.39B | $2.33B | $2.30B | $2.30B | -40.3% |
| Total assets | $5.53B | $5.96B | $5.36B | $4.99B | -7.2% |
| Total current liabilities | $525.19M | $577.92M | $885.78M | $388.33M | -9.1% |
| Current debt | $28.44M | $76.82M | $29.22M | $21.25M | -63.0% |
| Long-term debt | $2.47B | $1.88B | $1.34B | $1.36B | +31.5% |
| Total debt | $2.64B | $2.09B | $1.50B | $1.53B | +26.8% |
| Total liabilities | $3.39B | $2.77B | $2.47B | $2.09B | +22.4% |
| Retained earnings | -$765.84M | $387.33M | $131.72M | $153.39M | -297.7% |
| Shareholder equity | $1.95B | $3.07B | $2.78B | $2.81B | -36.6% |
| Working capital | $288.94M | -$427.00K | -$289.78M | $117.80M | +67,768.6% |
| Net tangible assets | $555.95M | $738.86M | $482.73M | $513.88M | -24.8% |
| Shares issued | 90.45M | 91.78M | 91.26M | 89.91M | -1.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$1.09B | $264.48M | -$15.66M | $280.03M | -512.9% |
| Depreciation & amortisation | $189.25M | $149.59M | $132.35M | $117.77M | +26.5% |
| Stock-based compensation | $31.71M | $37.11M | $32.29M | $29.64M | -14.6% |
| Change in working capital | -$8.67M | -$405.88M | $6.63M | -$69.35M | +97.9% |
| Operating cash flow | $131.90M | $129.69M | $462.34M | $380.57M | +1.7% |
| Capital expenditure | -$571.81M | -$690.38M | -$424.13M | -$296.15M | +17.2% |
| Investing cash flow | -$556.21M | -$736.48M | -$397.22M | -$305.83M | +24.5% |
| Share buybacks | -$50.03M | $0 | $0 | — | — |
| Financing cash flow | $481.25M | $583.02M | -$62.70M | -$110.90M | -17.5% |
| Free cash flow | -$439.91M | -$560.69M | $38.21M | $84.42M | +21.5% |
| End cash position | $133.24M | $76.31M | $100.07M | $97.65M | +74.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $865.84M | $828.80M | $821.46M | $851.57M | $869.23M | +4.5% |
| Operating revenue | $865.84M | $828.80M | $821.46M | $851.57M | $869.23M | +4.5% |
| Cost of revenue | $30.20M | $29.49M | $30.76M | $30.41M | $28.53M | +2.4% |
| Gross profit | $835.64M | $799.31M | $790.70M | $821.16M | $840.70M | +4.5% |
| Selling, general & admin | $541.70M | $531.97M | $521.20M | $525.38M | $514.99M | +1.8% |
| Total operating expense | $747.87M | $715.48M | $743.05M | $701.64M | $698.40M | +4.5% |
| Operating income | $87.77M | $83.84M | $47.64M | $119.52M | $142.30M | +4.7% |
| Net interest income | -$38.18M | -$38.33M | -$37.92M | -$36.62M | -$35.14M | +0.4% |
| Pre-tax income | $22.01M | $10.96M | -$1.17B | $39.98M | $50.00M | +100.7% |
| Tax provision | $9.75M | $6.50M | $7.84M | $1.67M | $12.07M | +50.0% |
| Net income | $10.93M | $4.11M | -$1.18B | $36.25M | $30.13M | +166.2% |
| Net income to common | $10.93M | $4.11M | -$1.18B | $36.25M | $30.13M | +166.2% |
| Basic EPS | 0.12 | 0.05 | -13.02 | 0.40 | 0.33 | +140.0% |
| Diluted EPS | 0.12 | 0.05 | -13.02 | 0.40 | 0.33 | +140.0% |
| EBIT | $60.19M | $49.29M | -$1.13B | $76.60M | $85.14M | +22.1% |
| EBITDA | $110.61M | $101.72M | -$1.09B | $124.07M | $134.14M | +8.7% |
| Basic shares | 90.82M | 90.53M | 90.44M | 90.41M | 90.33M | +0.3% |
| Diluted shares | 91.37M | 90.86M | 90.44M | 90.58M | 90.44M | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $171.29M | $158.47M | $133.24M | $118.69M | $131.42M | +8.1% |
| Cash & short-term investments | $171.29M | $158.47M | $133.24M | $118.69M | $131.42M | +8.1% |
| Accounts receivable | $470.75M | $471.75M | $440.60M | $430.84M | $408.54M | -0.2% |
| Inventory | $6.26M | $5.93M | $5.69M | $6.25M | $5.82M | +5.6% |
| Total current assets | $845.29M | $837.20M | $814.14M | $747.96M | $691.56M | +1.0% |
| Property, plant & equipment | $3.23B | $3.24B | $3.25B | $3.21B | $3.18B | -0.3% |
| Goodwill & intangibles | $1.40B | $1.40B | $1.39B | $2.37B | $2.36B | +0.2% |
| Total assets | $5.55B | $5.55B | $5.53B | $6.41B | $6.31B | -0.0% |
| Total current liabilities | $537.58M | $489.36M | $525.19M | $517.92M | $523.71M | +9.9% |
| Current debt | $32.50M | $32.50M | $28.44M | $24.38M | $20.31M | 0.0% |
| Long-term debt | $2.38B | $2.49B | $2.47B | $2.28B | $2.25B | -4.5% |
| Total debt | $2.57B | $2.67B | $2.64B | $2.43B | $2.39B | -3.9% |
| Total liabilities | $3.35B | $3.38B | $3.39B | $3.12B | $3.08B | -0.7% |
| Retained earnings | -$750.81M | -$761.74M | -$765.84M | $411.67M | $375.42M | +1.4% |
| Shareholder equity | $1.98B | $1.96B | $1.95B | $3.12B | $3.08B | +1.1% |
| Working capital | $307.71M | $347.84M | $288.94M | $230.03M | $167.85M | -11.5% |
| Net tangible assets | $575.66M | $558.28M | $555.95M | $748.69M | $722.29M | +3.1% |
| Shares issued | 90.87M | 90.76M | 90.45M | 90.43M | 90.39M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $12.26M | $4.46M | -$1.18B | $38.32M | $37.94M | +174.6% |
| Depreciation & amortisation | $50.43M | $52.43M | $45.75M | $47.47M | $48.99M | -3.8% |
| Stock-based compensation | $10.99M | $7.96M | $6.45M | $6.03M | $10.55M | +38.1% |
| Change in working capital | $71.74M | -$14.09M | $33.45M | -$32.68M | $44.14M | +609.3% |
| Operating cash flow | $162.07M | $61.53M | -$86.29M | $73.21M | $133.50M | +163.4% |
| Capital expenditure | -$38.55M | -$76.56M | -$93.19M | -$136.24M | -$167.75M | +49.6% |
| Investing cash flow | -$32.68M | -$60.21M | -$92.44M | -$129.75M | -$150.78M | +45.7% |
| Share buybacks | $0 | $0 | $0 | $0 | -$3.15M | — |
| Financing cash flow | -$116.57M | $23.91M | $193.28M | $43.82M | $57.46M | -587.5% |
| Free cash flow | $123.51M | -$15.03M | -$179.48M | -$63.03M | -$34.24M | +921.6% |
| End cash position | $171.29M | $158.47M | $133.24M | $118.69M | $131.42M | +8.1% |
Options analytics
Put / call volume
0.11
Call-heavy session
Put / call open interest
0.57
Positioning, not flow
Max pain
30.00
+3.3% from spot
ATM implied vol
48.9%
Nearest strike to spot
Skew (10% OTM)
+33.1%
Puts bid over calls
Call volume
123
Contracts, this expiry
Put volume
13
Contracts, this expiry
Heaviest call OI
30.00
671 contracts
Heaviest put OI
25.00
292 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.35 | 0.38 | +9.7% |
| Mar 2026 | 0.26 | 0.37 | +39.7% |
| Dec 2025 | 0.01 | 0.07 | +593.1% |
| Sep 2025 | 0.66 | 0.72 | +9.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.47 | 12 | $877.80M | +3.1% |
| Next quarter | 0.33 | 12 | $855.59M | +4.2% |
| Current year | 1.55 | 13 | $3.43B | +3.5% |
| Next year | 1.85 | 13 | $3.63B | +5.8% |
Analyst targets & ownership
Mean target$33.79
High target$41.00
Low target$17.00
Implied upside16.34%
Analyst count14
ConsensusBUY
Strong buy / Buy2 / 6
Hold5
Sell / Strong sell0 / 1
Held by insiders1.54%
Held by institutions147.29%
Institutions holding430
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
28.08
+3.44% from price
SMA 20
28.21
+2.93% from price
SMA 50
28.99
+0.17% from price
SMA 100
28.36
+2.38% from price
SMA 200
24.32
+19.43% from price
EMA 12
28.24
+2.83% from price
EMA 26
28.41
+2.22% from price
EMA 50
28.64
+1.41% from price
RSI (14)
53.9
Neutral
MACD (12,26,9)
-0.17
Hist 0.13
ATR (14)
1.14
3.93% of price
Realised vol 30D
38.9%
Annualised
Bollinger upper
29.33
20, 2σ
Bollinger lower
27.09
20, 2σ
50 / 200 cross
Golden
28.99 vs 24.32
Trend bias
Above 200
+19.43%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.90
Less volatile than market
Correlation to SPY
0.18
Largely independent
Realised vol 30D
38.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-57.1%
Peak to trough
Max drawdown 5Y
-86.9%
Peak to trough
ATR 14
1.14
3.93% of price
Beta (reported)
0.63
5Y monthly, from filing
Short interest
Shares short
21.51M
Prior 20.95M
Change vs prior
+2.7%
Shorts adding
% of float
35.48%
Heavily shorted
% of shares out
23.10%
Against total outstanding
Days to cover
14.3
Crowded exit
Float
91.53M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 23, 26 | Leerink Partners | MAINTAINED | Market Perform | Market Perform |
| Jul 30, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 20, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 14, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jul 14, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Jul 9, 26 | UBS | MAINTAINED | Buy | Buy |
| Jun 3, 26 | Jefferies | UPGRADE | Hold | Buy |
| May 4, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| May 4, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| May 1, 26 | Cantor Fitzgerald | MAINTAINED | Neutral | Neutral |
| May 1, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:4
Split dateNov 1, 2011
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-25
Corporate Changes & Voting Matters
8-K · 2026-07-28
Corporate Changes & Voting Matters
8-K · 2026-05-18
Offering Registrations
S-8 · 2026-05-11
Corporate Changes & Voting Matters
8-K · 2026-05-06
Periodic Financial Reports
10-Q · 2026-04-30
Corporate Changes & Voting Matters
8-K · 2026-04-29
Corporate Changes & Voting Matters
8-K · 2026-04-23
Headlines
Acadia Healthcare (ACHC) Upgraded to Buy: Here's What You Should Know
Zacks · 2d ago
2 Safe-and-Steady Stocks for Long-Term Investors and 1 We Find Risky
StockStory · 2d ago
Is Acadia Healthcare (ACHC) Outperforming Other Medical Stocks This Year?
Zacks · 2d ago
Roblox downgraded, Royal Caribbean upgraded: Wall Street's top analyst calls
The Fly · 9d ago
3 Cash-Burning Stocks We Think Twice About
StockStory · 9d ago
Here Are Monday’s Top Wall Street Analyst Research Calls: Applied Digital, Autodesk, Datadog, First Solar, L3Harris Technologies, PepsiCo, Roblox, Snowflake, TeraWulf and More
24/7 Wall St. · 9d ago
Raymond James Downgrades Acadia Healthcare to Outperform From Strong Buy
MT Newswires · 9d ago
Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement
Business Wire · 11d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.